Chartered Public Accountant

Université Paris Dauphine - PSL

Growth, Innovation & Impact Alternative Investments - Investor, Entrepreneur & Fund Manager

- Advisor to innovative companies / sophisticated investors with respect to various corporate finance/strategy/development/management challenges.
- Also, Absolute Return, Multi-Strategy, Global, Hedge portfolios inception & active management.
As a matter of expertise as well of philosophy, focus on ESG investments in disruptive players, on a global scale, within the main following industries: Life Sciences & Biotechnologies, Cleantech & Renewables, Information & Communication Technologies, Financial Technologies, Digital Transformation.

Technology, Life Sciences & Impact Investments

Senior Advisor

TheHive by Gvahim is an international startups accelerator program. It operates two programs in Israel (Tel-Aviv and Ashdod), providing entrepreneurs with tools and mentoring to create and develop their startup. Corporate Strategy, Corporate Finance & Business Development Advisory to multiple startups. Member of Jury Panels at startups competitions.

TheHive - Startups Accelerator

Venture Capital Mentor

Member of the Senior Executive Team - Leading the Investments and Business Development endeavors of Hutchison Kinrot. Global leading early-stage investor in Clean-tech, Environment & Impact-related technologies and the operator of a technology incubator in Israel, under a franchise from the Israeli Innovation Authority (Ministry of Economy and Industry). Hutchison Kinrot was acquired at the end of 2012 by Hutchison Water which is supported by global conglomerate CK Hutchison Holdings Limited. CK Hutchison has five core businesses: Ports and related services, Retail, Infrastructure, Energy and Telecommunications.
Hutchison Kinrot's investment thesis spans the whole spectrum of: Cleantech, Renewables, AgTech, Water, Smart Cities, Advanced Materials, Energy & Energy-related technologies, Cleantech related IT & IoT technologies. The Incubator enables promising early-stage companies to gain access to the highest levels of strategy, business, financial, operational and technical expertise.

In charge of the elaboration of the corporate strategy, and of the implementation of its correlative business plan with direct responsibilities for:
- Heading the investment process: from investment thesis conception, through deal-flow sourcing, investment opportunities screening (including full due diligence), deal structuring and ending by the negotiation and closing stage.
- Fueling the business development & marketing efforts of the firm: tailoring strategic partnerships with top-notch investors, leading corporations and other market players worldwide, as well as defining and deploying the marketing & communication strategy of the firm.
- Assisting portfolio companies through ongoing strategic advice, business development (pilots/JVs/cooperations), corporate finance (fundraising/M&A)/disposals) & management teams building /reorganization support.

Hutchison Kinrot

Director of Corporate Development - Impact VC / Incubator under the Israel Innovation Authority 

Teaching Corporate Strategy & Corporate Development as well as Management & Financial Control at the international MBA program of the world leading business school dedicated to Hospitality, Tourism and F&B businesses, with 7000 students and 31 campuses worldwide.

Vatel International Business School

Lecturer - International MBA - Corporate Strategy & Development / Management & Financial Control

Medical Devices, Ophthalmology & Medical Cannabis listed company (TASE: INCR). 
Notably involved in:
- Corporate restructuration process and corporate governance improvement;
- e-marketing strategy re-definition 
- Definition and implementation of different business development paths;
- Examination and negotiation processes of several M&A options.

InterCure

Member of the Board of Directors & Chairman of the Strategy Committee

- Inception, development & management of a unique Investment Banking & Business Advisory practice within the Israel-related business & investments landscape. Expertise in Innovation related ventures involving private equity and/or strategic transactions and this, notably on the Europe-Israel business & investments axis. Joined over time by 11 complementary top-notch venture partners, based both in Israel and within Europe.
- Operations: Advisory to Israeli & foreign companies, entrepreneurs, VC/PE investors & large corporations notably within the High-Tech, Life Sciences, FinTech, CleanTech, Ag-Tech & Real Estate fields : business strategy definition and business & financial planning assistance, launching accompaniment of business operations, European & Israeli markets penetration BD assistance notably via partnerships set-up, corporate finance advisory (fundraising / investment scouting / M&A), management advisory (incl. Boards of Directors positions), organizational consulting,  Jury/Mentor at highly-regarded startups contests.

NFI Blue Consulting

Managing Partner - Innovation-related Corporate Finance & Strategy Consulting

Biopharmaceuticals listed company (TASE: XTL; NASDAQ: XTLB). 
Notably involved in:
- Complete corporate strategy redefinition and business turnaround; 
- Capital raising processes from private investors, on the Tel-Aviv Stock Exchange and NASDAQ; 
- Mergers, acquisitions, investments, divestments: pharmaceutical and medical devices companies and assets.

XTL Biopharmaceuticals Ltd.

Member of the Board of Directors and of the Audit & Compensation Committees

Largest institutional investor in Israel. 
In charge of strategy definition, management & development of a global alternative investments portfolio ($1 billion) through both:
  - a Fund-of-Funds activity : investment worldwide in ~ 80 Venture Capital, Private Equity, Credit, Real Estate, Infrastructures & Hedge funds, as well as in strategic fields for the Group
- a direct global investments arm : set-up of Real-Estate JVs with strategic partners (Development stage large scale projects),  investment in RE yield producing assets , as well as in mature companies in different business sectors

Harel Insurance & Finance

Head of the Alternative Investments Division

CEO of one of SGPA portfolio companies (see below) operating in France in the Retail field, then in distressed situation, for restructuration and turnaround purposes. 31 stores of ~1.000 sqm each across the country / 130 people / products development and sourcing in France, China & Italy.
Lead the exit process from a severe management crisis situation, repositioned the brand (products ranges/marketing strategy/stores design), lead the e-Commerce activity launching (amongst other business development endeavors), reorganized the work force, improved the financial & legal situations.

Authentica - Retail company

Chief Executive Officer

Family-related holding company investing in mature, growth & early-stage Distribution & Consumer Goods companies (B2B / B2C) - notably through LBO operations.
- Screening and execution of new investments & build-ups for the group 
- Supervision (BoD positions), rationalization and development of the portfolio companies businesses (7 companies / 350 people)

SGPA sas

Director of Investments & Strategic Development

Creation, development & management of an international practice within RBI (Europe, NoAm, Asia), dedicated to leading VC/PE funds & large corporations: Transaction Advisory Services (strategic, financial & legal due diligence missions), Corporate Finance (M&A) & Business Consulting within the High-Tech, CleanTech & Life Sciences fields.

Russell Bedford International

Director - Private Equity Group

Leading Israeli Investment House (acquired by Excellence) - in strategic alliance with US Bancorp Piper Jaffray. Contribution to the management & new investments processes of the AG-Tech Fund, a  Life Sciences (Biopharmaceuticals / Medical Devices / Diagnostics) & AgriTech VC fund. 
Support to portfolio companies. BoD positions.

Piper Jaffray

Vice President - Venture Capital - Nessuah  Zannex Investment House

Nesssuah Zannex Venture Capital's portfolio company (see above) having developed the SteriMed System (medical waste treatment and disposal system, generating an eco-friendly output raw material). 
Appointed MD of the company- instrumental contribution to the complete  turnaround and to the sale process of the majority interest in MCM Inc. to Caprius (USA).

MCM Environmental Technologies

Managing Director

- Co-Founder of the KPMG Technology Group in Israel (Somekh Chaikin - previously PW Israel): corporate finance, TAS & strategy consulting department dedicated to High-Tech, Life Sciences & CleanTech companies.
- Previously - career begun at the firm French office (PW): financial & operational Audit missions at major French and international corporations. Involved in several M&A, transaction services and appraisals missions for leading corporations.

Marc Allouche